<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00970047</url>
  </required_header>
  <id_info>
    <org_study_id>SQNM-FS-101</org_study_id>
    <nct_id>NCT00970047</nct_id>
  </id_info>
  <brief_title>Development of a Fetal Sex Assay From Maternal Whole Blood</brief_title>
  <official_title>Development of a Noninvasive Fetal Sex Determination Test Between 6 and 16 Weeks of Gestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sequenom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sequenom, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study whereby samples will be tested to determine the presence or
      absence of fetal Y chromosome genes to test for the fetal sex of the baby. The blood draw
      will occur between 6 to 16 weeks of gestation. The fetal gender will be requested at or soon
      after delivery if fetal sex was not previously obtained by CVS or amniocentesis genetic
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Fetal Sex Determination</condition>
  <arm_group>
    <arm_group_label>Pregnant females</arm_group_label>
    <description>Women who are pregnant and between 6 and 16 weeks of gestation and who are 18 to 64 years of age.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and PBMCs
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women between 6 and 16 weeks of gestation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 18-64 years of age

          -  Subject is female

          -  Subject is pregnant and between 6 and 16 weeks of gestation

          -  Subject provides a signed and dated informed consent

          -  If subject undergoes a routine ultrasound between weeks 16 and 28, she agrees to
             provide the fetal sex results

          -  If subject undergoes an invasive procedure, she agrees to provide the fetal sex
             results

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allan Bombard, MD, MBA</last_name>
    <role>Study Director</role>
    <affiliation>Sequenom, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NCOG Medical Group</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IGO</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic Medial Group</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2009</study_first_submitted>
  <study_first_submitted_qc>September 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2009</study_first_posted>
  <last_update_submitted>January 31, 2011</last_update_submitted>
  <last_update_submitted_qc>January 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Allan Bombard / Chief Medical Officer</name_title>
    <organization>Sequenom, Inc.</organization>
  </responsible_party>
  <keyword>pregnant</keyword>
  <keyword>fetal sex determination</keyword>
  <keyword>gender determination</keyword>
  <keyword>noninvasive test</keyword>
  <keyword>fetal DNA</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

